Hepta reports its AI-based blood test matched MRE in identifying treatment-eligible MASH fibrosis in an independent Madrigal ...

Thermo Fisher Scientific introduces AmpSure Universal SYBR Green and Probe Master Mixes, offering value-priced qPCR reagents.

Agilent has acquired digital pathology software firm Proscia for $240 million, adding an FDA-cleared platform to its ...

Siemens Healthineers will separate its in vitro diagnostics business as Olyrian Diagnostics, aiming to complete the transition by mid-2028.

Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...

A study links early donor-derived cell-free DNA patterns to kidney transplant outcomes, including rejection and graft loss.

A study found Lucid’s nonendoscopic EsoCheck device achieved a 95% sample collection rate for esophageal precancer testing in ...

FDA clears Cepheid’s Xpert Hemorrhagic Fever Panel, a multiplex PCR test for Ebola, Marburg, Lassa, and Crimean-Congo viruses ...

A study in Gynecologic Oncology reports that a Mercy BioAnalytics blood test measuring cancer-linked proteins may detect ...

Pillar Biosciences introduces the MRDTect NPM1 and FLT3 ITD NGS panel for in-house acute myeloid leukemia MRD detection.

FDA clears Roche cobas eplex RP3 panel, which detects up to 19 respiratory pathogen and adds Bordetella pertussis.

A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.